查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541187

2024-2032 年按类型、技术、应用、最终用途和地区分類的可穿戴注射器市场报告

Wearable Injectors Market Report by Type, Technology, Application, End Use, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球穿戴式註射器市场规模达77亿美元。由于慢性病盛行率的增加、对个人化医疗的日益关注、医疗保健成本的增加（刺激了可穿戴注射器的采用以实现高效药物输送）、对家庭治疗方案的日益偏好、生物製药管道的快速扩张、推动该市场正在经历显着成长。

穿戴式註射器市场分析：

主要市场驱动因素：慢性病治疗范围的扩大以及更有针对性和更有效的给药方法的必要性正在推动市场成长。由于更好的可用性和客製化功能而受到患者和医护人员的欢迎，可穿戴注射设备的持续技术进步正在推动市场成长。

主要市场趋势：开发具有穿戴式装置的注射器的趋势日益明显，这些装置配备了剂量控制和自我给药等附加功能，从而提高了患者的便利性和治疗依从性。除此之外，注射器的出现与数位健康平台和行动应用程式相结合，有助于远端患者监测、即时资料收集和个人化医疗服务的进步，从而推动市场成长。

地理趋势：在这些地区中，北美是穿戴式註射器的领先市场，主要是因为主要产业参与者的存在、尖端技术以及先进医疗保健技术的高采用率。由于一系列基础设施因素，例如优惠的监管框架、不断增加的医疗保健投资以及人们对自我管理设备的认识不断增强，欧洲市场正在经历大幅增长。

竞争格局：穿戴式註射器产业的一些主要市场参与者包括 Becton Dickinson and Company、CeQur SA、Debiotech SA、Dexcom Inc.、Enable Injections Inc.、Gerresheimer AG、Insulet Corporation、Tandem Diabetes Care Inc.、West Pharmaceutical Services Inc .、Ypsomed AG. 等。

挑战与机会：市场面临监管复杂性和报销挑战等挑战，同时也提供了向以患者为中心过渡的机会。财务限制和长期临床证据也是市场扩张的主要障碍之一。

穿戴式註射器市场趋势：

慢性病盛行率增加

全球慢性疾病（糖尿病、癌症和心血管疾病）发生率的上升是注射器市场的主要刺激因素。从长远来看，那些需要全职药物管理的情况，可穿戴式註射器为患者提供了一种简单有效的解决方案，患者可以简单地给药，没有麻烦和一致性。慢性病盛行率的上升导致穿戴式註射器领域的需求成长。这些注射器为患者提供随时随地管理健康状况的便利性。例如，根据国家医学图书馆 (NLM) 的数据，近一半的美国人患有至少一种慢性疾病，约有 1.33 亿人受到影响。这些资料说明了医疗保健系统的慢性病工作量不断增加，并说明了迫切需要采取强有力的管理行动，其中包括成功采用最新解决方案（例如可管理注射器），以改善患者的治疗结果和生活方式。

持续的技术进步：

穿戴式註射器技术的不断进步促进了全新的药物输送方法并推动了产业的成长。穿戴式科技包括与行动装置连接、剂量监测功能和自动药物传输机制等功能，最终从使用者的角度改善治疗体验和依从性。随着更多用户友好、紧凑和智慧注射器的出现，它们越来越受到人们的认可，而医疗保健提供者也能够利用它们来制定更个人化和准确的药物传输系统。穿戴式註射器对数位健康平台的直接管理进一步提高了系统的效率，使得脱离接触的检查和数据驱动的健康管理成为可能。例如，根据美国国家卫生研究院(NIH) 的数据，2020 年第一季度，美国远距医疗的使用量增加了154%，到2022 年，80% 的受访者透过远距医疗获得护理，高于72 % 2021 年的百分比。

人们越来越偏爱家庭治疗方案：

由于快速转向以患者为中心的医疗保健和注射器的便携性作为诊所治疗的有吸引力的替代品，向家庭医疗保健的转变正在推动市场成长。根据 IMARC GROUP 发布的报告，美国家庭医疗保健市场预计 2024 年至 2032 年的年复合成长率(CAGR) 为 7.4%。患者非常重视方便的自我给药，并且允许他们在家中这样做，即时见证药物对他们健康的正面影响。慢性病管理需要持续坚持治疗方案；因此，这种趋势在这些情况下尤其突出。穿戴式註射器在医疗保健系统中发挥越来越重要的作用，因为它们允许患者控制自己的治疗结果，这有助于节省医疗成本，同时提高患者的满意度。

穿戴式註射器市场细分：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据类型、技术、应用和最终用途对市场进行了分类。

按类型划分：

贴身

离体

On-body占据大部分市场份额

该报告根据类型提供了详细的市场细分和分析。这包括体内和体外。根据该报告，体用产品占据了最大的市场份额。

市面上穿戴式穿戴式註射器的主要驱动因素是其便利性、易用性以及提高治疗顺从性的潜力。这些设备设计为直接佩戴在身体上，为患者提供谨慎且免提的药物输送解决方案。透过消除手动注射的需要并提供可客製化的给药方案，体内可穿戴注射器使患者能够方便地自行给药，而无需中断其日常活动。此外，剂量监测和连接等先进功能的整合增强了患者的参与度，并允许医疗保健提供者进行远端监测，进一步推动了市场上可穿戴式註射器的采用。例如，MEDTRONIC 于 2021 年 4 月推出了一款输液器，将胰岛素从帮浦输送到体内，展示了体内穿戴式註射器技术的进步。这项创新使输液器的佩戴时间延长了一倍，使患者可以安全地继续胰岛素帮浦治疗，减少中断和插入，同时在糖尿病管理常规中享受更大的便利和舒适。

按技术划分：

基于弹簧

马达驱动

旋转泵

膨胀电池

其他的

Spring基占据产业最大份额

报告还提供了基于该技术的详细市场细分和分析。这包括弹簧式、马达驱动式、旋转帮浦、膨胀电池等。报告称，弹簧型占了最大的市场份额。

可穿戴注射器基于弹簧的原理以其简单、可靠和经济实惠的众所周知的特点而建立。这些药物使用弹簧式机械机构进行分配，使其独立于复杂的电子设备或电源。这种消除确实降低了生产成本并提高了耐磨喷射器的耐用性和可靠性，使得它们适合长期使用。此外，弹簧注射器在药物传输方面具有完美的精确度和确定性，消除了药物水平误差并最大限度地提高了患者的治疗效果。从患者和医疗保健提供者的角度来看，这些设备因其简单的设计和作为弹簧底座可穿戴注射器的长期经过验证的结果而脱颖而出。例如，BECTON DICKINSON（美国公司）就是着名的创新者，BD（Libertas）提供的弹簧喷油嘴就是这样的创新之一。这种先进的药物传输系统是一种独特的基于弹簧的发电机，可以节省电池或消除透过放电去除重金属的情况。

按应用划分：

肿瘤学

传染病

心血管疾病

自体免疫疾病

其他的

肿瘤学代表了领先的细分市场

该报告根据应用程式提供了详细的市场细分和分析。这包括肿瘤学、传染病、心血管疾病、自体免疫疾病等。根据该报告，肿瘤学占最大的部分。

肿瘤学中越来越多地采用穿戴式註射器，是因为患者对舒适、方便以及坚持治疗方案的要求不断提高。大多数与肿瘤疾病（癌症）作斗争的人通常需要长期、频繁地服用化疗药物；身体和精神上都疲惫不堪的情况。据国家癌症研究所称，仅 2020 年，美国就诊断出约 1,806,590 例新癌症病例，并有 606,520 人因癌症死亡。摄护腺癌、肺癌和结肠癌是主要类型，其次是其他癌症类型，在新诊断的癌症中占很大比例。穿戴式註射器可以提供使用者友善的解决方案，确保药物持续、受控地输送给患者，并允许他们在医院环境之外接受治疗，例如需要静脉注射几个小时的癌症患者。患者的生活品质除了改善外，还可以促进治疗依从性，使患者能够定期服药；因此，他们从这些抗癌措施中获得了更好的结果。

按最终用途细分：

医院和诊所

居家护理

其他的

居家照护在市场上表现出明显的主导地位

报告还提供了基于最终用途的详细市场细分和分析。这包括医院和诊所、家庭护理等。报告显示，家庭护理占最大的市场份额。

在以患者为中心的医疗保健提供技术以及对使用简单且具有成本效益的治疗方法的日益增长的需求中，使用可穿戴注射器的家庭护理环境的增长趋势引人注目。个人协助使患者能够在家庭环境中控制医疗状况，提供舒适性和自主性。穿戴式註射器派上用场，因为它们有助于自我给药，这可以防止患者由于治疗的性质而必须去医院就诊。此外，结合了剂量监测和连接设备的注射器设备构成了可穿戴技术的另一项创新，这对患者的安全感具有重要影响，并使医疗保健提供者能够进行远端监控，从而进一步提高了它们在家庭照护中的普及。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美市场领先，占据最大的穿戴式註射器市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是穿戴式註射器最大的区域市场。

北美插管注射器市场的主要参与者主要是由于其拥有世界上最完善的医疗保健系统，人均医疗保健支出最高，从而使创新医疗技术很容易被广泛接受。此外，日益增长的慢性疾病和人口老化对便利且高效的药物输送解决方案提出了挑战，导致对穿戴式註射器的需求增加。最后，具有权威和技术进步的市场参与者的存在为市场的成长和创新提出了要求。此外，有利的报销政策和有利的监管氛围进一步推动了北美对穿戴式註射器的接受度，为全球穿戴式註射器市场做出了贡献。例如，根据 IMARC GROUP 发布的报告，美国穿戴式註射器市场规模在 2024 年至 2032 年期间将以 5.30% 的复合年增长率成长。

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。穿戴式註射器产业的一些主要市场参与者包括 Becton Dickinson and Company、CeQur SA、Debiotech SA、Dexcom Inc.、Enable Injections Inc.、Gerresheimer AG、Insulet Corporation、Tandem Diabetes Care Inc.、West Pharmaceutical Services Inc. 和伊普索梅德股份公司。

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

穿戴式註射器市场的主要参与者正在创新，以进一步改进功能并了解患者不断变化的需求。一些最新的创新包括智慧型穿戴注射器的出现，这些注射器具有连接、剂量感应和自动驾驶等高端功能。此外，许多公司已经推出了具有蓝牙连接功能的可穿戴注射器，使患者能够监控其药物摄入量并透过手机接收提醒。此外，小型化和设计的进步导致了不显眼且更舒适的可穿戴注射器的开发，这对患者对治疗的接受度和依从性产生了积极影响。这些创新凸显了主要参与者为提供整洁的产品所做的努力，以满足患者的生活方式和治疗效果。

穿戴式註射器市场新闻：

2023 年 2 月 16 日：Insulet Corporation 收购了 Automated Glucose Control LLC (AGC) 的资产，该公司专注于自动胰岛素输送技术的开发和商业化，展示了他们对穿戴式註射器领域创新的承诺。

2023 年 3 月 17 日：Tandem 收购了输液器开发商 Capillary Biomedical，显示其在穿戴式註射器市场的策略性倡议。这表明 Tandem 不断致力于透过向医疗设备供应其产品来实现创新和成长。 Tandem 对 Capillary Biomedical 的收购使其输液器技术得以实现，并将其与其可穿戴注射器解决方案系列相结合，从而增强了其在行业中的地位。

本报告回答的关键问题：

  • 迄今为止，全球穿戴式註射器市场表现如何，未来几年将如何表现？
  • 全球穿戴式註射器市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球穿戴式註射器市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的穿戴式註射器市场？
  • 依类型划分市场是怎么样的？
  • 哪种类型是穿戴式註射器市场中最具吸引力的类型？
  • 什么是基于技术的市场分割？
  • 穿戴式註射器市场中哪一项技术最具吸引力？
  • 基于应用的市场区隔是什么？
  • 穿戴式註射器市场中哪项应用最具吸引力？
  • 根据最终用途分類的市场是怎样的？
  • 穿戴式註射器市场中最具吸引力的最终用途是什么？
  • 市场竞争结构如何？
  • 全球穿戴式註射器市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 迄今为止，全球穿戴式註射器市场表现如何，未来几年将如何表现？
  • 全球穿戴式註射器市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球穿戴式註射器市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的穿戴式註射器市场？
  • 依类型划分市场是怎么样的？
  • 哪种类型是穿戴式註射器市场中最具吸引力的类型？
  • 什么是基于技术的市场分割？
  • 穿戴式註射器市场中哪一项技术最具吸引力？
  • 基于应用的市场区隔是什么？
  • 穿戴式註射器市场中哪项应用最具吸引力？
  • 根据最终用途分類的市场是怎样的？
  • 穿戴式註射器市场中最具吸引力的最终用途是什么？
  • 市场竞争结构如何？
  • 全球穿戴式註射器市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球穿戴式註射器市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 贴身
    • 市场趋势
    • 市场预测
  • 离体
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依技术

  • 基于弹簧
    • 市场趋势
    • 市场预测
  • 马达驱动
    • 市场趋势
    • 市场预测
  • 旋转泵
    • 市场趋势
    • 市场预测
  • 膨胀电池
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按应用

  • 肿瘤学
    • 市场趋势
    • 市场预测
  • 传染病
    • 市场趋势
    • 市场预测
  • 心血管疾病
    • 市场趋势
    • 市场预测
  • 自体免疫疾病
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：最终用途别

  • 医院和诊所
    • 市场趋势
    • 市场预测
  • 居家护理
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Becton Dickinson and Company
    • CeQur SA
    • Debiotech SA
    • Dexcom Inc.
    • Enable Injections Inc.
    • Gerresheimer AG
    • Insulet Corporation
    • Tandem Diabetes Care Inc.
    • West Pharmaceutical Services Inc.
    • Ypsomed AG
Product Code: SR112024A3992

The global wearable injectors market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.4 Billion by 2032, exhibiting a growth rate (CAGR) of 13.4% during 2024-2032. The market is experiencing significant growth driven by increasing prevalence of chronic diseases, growing focus on personalized medicine, heightening healthcare costs that incentivize the adoption of wearable injectors for efficient drug delivery, rising preference for home-based treatment options, rapid expansion of biopharmaceutical pipeline, and ongoing technological advancements.

Wearable Injectors Market Analysis:

Major Market Drivers: The rising scope of chronic diseases treatments and the necessity for more targeted and effective drug delivery methods are propelling the market growth. Ongoing technological advancements in wearable injection devices due to better usability and customization features that have become popular for patients and healthcare workers are fueling market growth.

Key Market Trends: There is a growing trend to develop injectors with wearable devices equipped with additional features like dose control and self-drug delivery, thereby improving patient convenience and therapy compliance. Apart from that, the emergence of injectors combining with digital health platforms and mobile applications is contributing to the advancement of remote patient monitoring, real-time data collection, and personalized healthcare delivery, thus fueling market growth.

Geographical Trends: Among the regions, North America is the leading market for wearable injectors primarily because of the existence of major industry players, cutting- edge technology and the high adoption rate of advanced healthcare technology. The market is experiencing substantial growth in Europe owing to the set of infrastructural factors like preferential regulatory framework, rising healthcare investment, and growing awareness around self-administration devices.

Competitive Landscape: Some of the major market players in the wearable injectors industry include Becton Dickinson and Company, CeQur SA, Debiotech SA, Dexcom Inc., Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Tandem Diabetes Care Inc., West Pharmaceutical Services Inc., Ypsomed AG., among many others.

Challenges and Opportunities: The market faces challenges such as the complexity of regulation and challenges with reimbursement whereas it also offers opportunities in transition to patient-centeredness. Financial limitations and long-term clinical evidence are also one of the major barriers to market expansion.

Wearable Injectors Market Trends:

Increasing prevalence of chronic diseases

The rising incidence of chronic illnesses across the globe (diabetes, cancer, and cardiovascular disorders), is the main stimulator of the injector market. Providing the long-term are those conditions that need full time medication management, and this is the wearable injectors come to offer a simple and effective solution to patients who can simply administer their medications without hassle and consistency. The rise in chronic diseases' prevalence leads to demand growth in a wearable injectors segment. These injectors provide patients with the convenience of managing their health conditions anywhere anytime. For instance, as per the NATIONAL LIBRARY OF MEDICINE (NLM), nearly half of all Americans suffer from at least one chronic disease, with approximately 133 million individuals affected. This data illustrates the increasing workload of chronic diseases for healthcare system and illustrates the pressing need for powerful management actions, among them the successful incorporation of latest solutions such as administrable injectors in order to improve patients' outcome and lifestyle.

Ongoing technological advancements:

The ongoing advancements in wearable injector technology promote completely new drug delivery methods and fuels industry growth. Wearable technologies comprise of features such as connectivity with mobile devices, dose monitoring capability, and automatic drug delivery mechanisms, which eventually improve the experience and adherence to the treatment from the user's perspective. Along with more user-friendly, compact, and intelligent injectors emerging, they are gaining more acceptance by a variety of people, while healthcare providers are being able to utilize them to formulate more individualized and accurate drug delivery systems. The direct administration of wearable injectors to digital health platforms increases the efficiencies of the system even more, making out-of-touch checkups, and data-driven health-management possible to use. For instance, according to the NATIONAL INSTITUTE OF HEALTH (NIH), in the US, there was a 154% increase in telehealth usage in the first quarter of 2020, with 80% of all respondents accessing care via telemedicine in 2022, up from 72% in 2021.

Growing preference for home-based treatment options:

The transition toward home-based healthcare due to the rapid shift to patient-centered health care and portability of injectors as an attractive alternative to clinic-based treatments is fueling market growth. The U.S. home healthcare market projected compound annual growth rate (CAGR) of 7.4 % from 2024 to 2032 as per the report published by IMARC GROUP. Patients really value the self-administration of medications that are convenient and allow them to do so at home, witnessing the positive effect on their health in real-time. Chronic disease management requires ongoing treatment regime adherence; therefore, this trend is especially prominent in those cases. Wearable injectors play an increasingly more important role in the healthcare system, as they allow patients to take control of their treatment outcomes, which helps save healthcare costs while also improving the patients' satisfaction.

Wearable Injectors Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, technology, application, and end use.

Breakup by Type:

On-body

Off-body

On-body accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes on-body and off-body. According to the report, on-body represented the largest segment.

The on-body type of wearable injectors in the market is primarily driven by its convenience, ease of use, and potential for improved treatment adherence. These devices are designed to be worn directly on the body, providing patients with a discreet and hands-free solution for medication delivery. By eliminating the need for manual injections and offering customizable dosing schedules, On-body wearable injectors empower patients to conveniently self-administer medications without interrupting their daily activities. Additionally, the integration of advanced features such as dose monitoring and connectivity enhances patient engagement and allows for remote monitoring by healthcare providers, further driving the adoption of On-body wearable injectors in the market. For instance, MEDTRONIC launched an infusion set in April 2021 that allows for the transport of insulin from the pump to the body, showcasing advancements in on-body wearable injector technology. This innovation doubles the length of time an infusion set can be worn so that patients can safely continue on insulin pump therapy with fewer interruptions and insertions while also enjoying greater convenience and comfort in their diabetes management routine.

Breakup by Technology:

Spring-based

Motor-driven

Rotary Pump

Expanding Battery

Others

Spring-based holds the largest share of the industry

A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes spring-based, motor-driven, rotary pump, expanding battery, and others. According to the report, spring based accounted for the largest market share.

The spring-based principle of wearable injectors is established by its well-known feature of simplicity, reliability, and affordability. These medications are dispensed using spring-type mechanical mechanisms that make them independent on complex electronics or power sources. This elimination does reduce the production costs and improves the resistance and reliability of the wearable injectors such that they are applicable for long term use. Moreover, the perfect precision and certainty of spring injectors in the delivery of the drugs, eliminates drug level errors and maximizes the therapeutic outcome of patients. The devices stand out from the perspective of both patients and health care providers due to their simple design and long-term proven results as spring-base wearable injectors. For instance, BECTON DICKINSON (U.S.-based company) is a well-known innovator, and the spring-based injector offered by BD (Libertas) is one such innovation. This advanced drug delivery system is a unique spring-based power generator that saves batteries or eliminates the removal of heavy metals through discharge.

Breakup by Application:

Oncology

Infectious Diseases

Cardiovascular Diseases

Autoimmune Diseases

Others

Oncology represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes oncology, infectious diseases, cardiovascular diseases, autoimmune diseases, and others. According to the report, oncology represented the largest segment.

The rising adoption of wearable injectors in oncology is attributed to the increasing requirements for patients to be comfortable and convenient, and to adhere to the treatment programme. Most individuals battling with oncology diseases (cancer) are often expected to take the chemotherapy drugs for long periods and in frequent doses; a situation that is both physically and emotionally exhausting. Approximately 1,806,590 new cancer cases were diagnosed, and 606,520 deaths caused by cancer happened in the USA in the year of 2020 alone as stated by the NATIONAL CANCER INSTITUTE. Prostate cancer, lung cancer, and colon cancer are the leading types, followed by other cancer types, taking up a significant percentage of new cancer diagnoses. Wearable injectors can offer a user-friendly solution by ensuring the drug is continuously and controlled delivered for patients and allowing them to receive their treatments outside the hospital environment, such as patients with cancer whose IVs will run for hours. Patients' quality of life, besides improving also facilitates treatment adherence which enables patients to take their medications regularly; hence they have better outcomes from these anti-cancer measures.

Breakup by End Use:

Hospitals and Clinics

Home Care

Others

Home care exhibits a clear dominance in the market

A detailed breakup and analysis of the market based on the end use have also been provided in the report. This includes hospitals and clinics, home care, and others. According to the report, home care accounted for the largest market share.

The growing trend of home care settings for the use of wearable injectors is notable among the patient-centric healthcare delivery techniques and the increasing demands for the use of easy and cost-effective treatment approaches. Personal assistance, which enables patients to control medical conditions in a home environment, provides comfort and autonomy. Wearable injectors come in handy as they help with self-administration of drugs, which prevents a patient from having to keep hospital visits due to the nature of his/her treatment. Moreover, injector devices that incorporate dose monitoring and connectivity equipment constitute another innovation in wearable technology which has important implications for the sense of security the patient can feel and enables remote monitoring by healthcare providers, only which further increase their popularity in home care.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest wearable injectors market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for wearable injectors.

The major players in the North American cannula injectors market are mainly due to its most sophisticated healthcare system in the world with the highest per capita healthcare spending, thus making it easy for innovative medical technologies to be widely embraced. Moreover, growing chronic diseases and an aging population posing the challenge of convenient and efficient drug delivery solutions result in an increased demand for wearable injectors. And lastly, the presence of market players with authority and technological evolution creates a requirement for growth and innovation of the market. Moreover, there is an availability of favorable reimbursement policies and conducive regulatory atmosphere which offers an extra boost for acceptance of wearable injectors in North America contributing to the global wearable injectors market. For instance, United States wearable injectors market size is exhibited to grow at a rate (CAGR) of 5.30 % during 2024-2032 as per the reports published by the IMARC GROUP.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the wearable injectors industry include Becton Dickinson and Company, CeQur SA, Debiotech SA, Dexcom Inc., Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Tandem Diabetes Care Inc., West Pharmaceutical Services Inc. and Ypsomed AG.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

The key players of wearable injectors market are innovating to further improve the features and understand the changing needs of the patients. Some of the latest innovations include the emergence of smart wearable injectors that come with high-end features such as connectivity, dose sensing and auto-driving among others. Moreover, many companies have already come up with wearable injectors which have Bluetooth connectivity that enables patients to monitor their medication intake and receive a reminder through their phones. Furthermore, the miniaturization and design advancements have resulted in the development of less conspicuous and more comfortable wearable injectors which have a positive impact on the acceptance and compliance with the treatment among patients. These innovations highlight the efforts of key players to provide clutter-free products that cater for the lifestyle of patients and therapeutic outcomes.

Wearable Injectors Market News:

Feburary 16, 2023: Insulet Corporation acquired the assets of Automated Glucose Control LLC (AGC), a company focused on developing and commercializing automated insulin delivery technology, showcasing their commitment to innovation in the wearable injectors sector.

March 17, 2023: Tandem acquired infusion set developer, Capillary Biomedical, indicating their strategic moves in the wearable injectors market. This indicates that Tandem is constantly aiming for innovation and growth by supplying its products to medical devices. Tandem's acquisition of Capillary Biomedical enables its infusion set technology, which it incorporated with its line of wearable injector solutions, thus empowering its stand in the industry.

Key Questions Answered in This Report:

  • How has the global wearable injectors market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global wearable injectors market?
  • What is the impact of each driver, restraint, and opportunity on the global wearable injectors market?
  • What are the key regional markets?
  • Which countries represent the most attractive wearable injectors market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the wearable injectors market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the wearable injectors market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the wearable injectors market?
  • What is the breakup of the market based on the end use?
  • Which is the most attractive end use in the wearable injectors market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global wearable injectors market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Wearable Injectors Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 On-body
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Off-body
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Spring-based
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Motor-driven
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Rotary Pump
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Expanding Battery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Infectious Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cardiovascular Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Autoimmune Diseases
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Home Care
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Becton Dickinson and Company
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 CeQur SA
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Debiotech SA
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Dexcom Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Enable Injections Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Gerresheimer AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Insulet Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Tandem Diabetes Care Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 West Pharmaceutical Services Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Ypsomed AG
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Wearable Injectors Market: Major Drivers and Challenges
  • Figure 2: Global: Wearable Injectors Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Wearable Injectors Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Wearable Injectors Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Wearable Injectors Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Wearable Injectors Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Wearable Injectors Market: Breakup by End Use (in %), 2023
  • Figure 8: Global: Wearable Injectors Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Wearable Injectors (On-body) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Wearable Injectors (On-body) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Wearable Injectors (Off-body) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Wearable Injectors (Off-body) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Wearable Injectors (Spring-based) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Wearable Injectors (Spring-based) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Wearable Injectors (Motor-driven) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Wearable Injectors (Motor-driven) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Wearable Injectors (Rotary Pump) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Wearable Injectors (Rotary Pump) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Wearable Injectors (Expanding Battery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Wearable Injectors (Expanding Battery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Wearable Injectors (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Wearable Injectors (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Wearable Injectors (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Wearable Injectors (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Wearable Injectors (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Wearable Injectors (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Wearable Injectors (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Wearable Injectors (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Wearable Injectors (Autoimmune Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Wearable Injectors (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Wearable Injectors (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Wearable Injectors (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Wearable Injectors (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Wearable Injectors (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Wearable Injectors (Home Care) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Wearable Injectors (Home Care) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Wearable Injectors (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Wearable Injectors (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: Wearable Injectors Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: Wearable Injectors Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: Wearable Injectors Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: Wearable Injectors Industry: SWOT Analysis
  • Figure 89: Global: Wearable Injectors Industry: Value Chain Analysis
  • Figure 90: Global: Wearable Injectors Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Wearable Injectors Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Wearable Injectors Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Wearable Injectors Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Wearable Injectors Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Wearable Injectors Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 6: Global: Wearable Injectors Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Wearable Injectors Market: Competitive Structure
  • Table 8: Global: Wearable Injectors Market: Key Players